Vaccinations against COVID-19 began in the U.K. on Tuesday. The vaccine, produced by Pfizer and partner BioNTech, has is also close to getting approval in the United States. But as NPR’s Frank Langfitt reports, vaccinating all of the U.K. could be further disrupted by ongoing Brexit negotiations.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org.